New combo therapy targets aggressive breast cancer in major trial
NCT ID NCT05909332
First seen Jan 22, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study tests whether adding an antivascular drug to standard chemotherapy helps prevent breast cancer from returning in people with a specific, high-risk type of triple-negative breast cancer. About 764 women with stage II to III cancer will receive either the combination or chemo alone. The goal is to see if the combo improves how long people stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, Jiangsu, 226006, China
Contact
Contact Phone: •••-•••-••••
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact Phone: •••-•••-••••
-
Breast cancer institute of Fudan University Cancer Hospital
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chongqing Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, 400030, China
Contact Phone: •••-•••-••••
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
Contact Phone: •••-•••-••••
-
Guangdong Academy of Medical Sciences Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-••••
-
Liaoning Cancer Hospital & Institute
RECRUITINGShenyang, Liaoning, 110801, China
Contact
Contact Phone: •••-•••-••••
-
Ningbo Medical Center Lihuili Hospital
RECRUITINGNingbo, Zhejiang, China
Contact Phone: •••-•••-••••
-
Northern Jiangsu People's Hospital
RECRUITINGYangzhou, Jiangsu, 225009, China
Contact Phone: •••-•••-••••
-
Shanghai First Maternity and Infant Hospital
RECRUITINGShanghai, Shanghai Municipality, 201204, China
Contact Phone: •••-•••-••••
-
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University
RECRUITINGShanghai, Shanghai Municipality, 200233, China
Contact Phone: •••-•••-••••
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangdong, Guangzhou, 510062, China
Contact Phone: •••-•••-••••
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi’an, Shanxi, 710061, China
Contact Phone: •••-•••-••••
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110002, China
Contact
Contact Phone: •••-•••-••••
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.